WINDSOR JAMES BRIAN
SEC CIK 1790933 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNTX | Rein Therapeutics, Inc. | See Remarks, Dir | 27.0K | $36.7K | — | 5 | 2023-11-20 | 2026-04-30 |
Most active insiders at RNTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Voss Value-Oriented Special Situations Fund, LP | 10% | $423.5K | — |
| 2 | Voss Value Master Fund, LP | 10% | $127.1K | — |
| 3 | VON RICKENBACH JOSEF H | Dir | $49.6K | — |
| 4 | WINDSOR JAMES BRIAN | See Remarks, Dir | $25.0K | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-13 08:47 | 2026-04-30 | RNTX | Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | See Remarks, Dir | P - Purchase | $1.00 | +25.0K | 27.0K | +1,222% | +$25.0K |
| MI | 2024-12-09 | 2024-12-05 | RNTX | Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | Pres, CEO | P - Purchase | $2.24 | +400 | 161 | New | +$897.61 |
| D | 2024-03-06 | 2024-03-05 | RNTX | Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | Pres, COO | M - OptEx | — | +2,000 | 7,122 | +39% | — |
| I | 2023-12-18 | 2023-12-15 | RNTX | Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | Pres, COO | P - Purchase | $3.37 | +225 | 225 | New | +$758.25 |
| 2023-11-21 | 2023-11-20 | RNTX | Rein Therapeutics, Inc. | WINDSOR JAMES BRIAN | Pres, COO | P - Purchase | $1.97 | +5,076 | 5,122 | +11,035% | +$10,000 |
Purchase Sale Sale after option exercise All abbreviations